Selected Data 1) The studies conducted by the research team of Kingsberg et al consisted of two identical, randomized, double-blind, placebo-controlled trials conducted across multiple centers to evaluate the safety and efficacy of bremelanotide administered via subcutaneous injection as needed in premenopausal women with hypoactive sexual desire disorder (HSDD)
Hickey, S., Roberts, H.J., & Miller, N.J
GLP-1 drugs are an emerging contributor
Presented at Digestive Disease Week (DDW) 2025, the study demonstrates how Phenomixs proprietary machine learning algorithms can predict which individuals are more likely to experience side effectsparticularly nauseawhen undergoing GLP-1 receptor agonist therapy
Produced by the body, its stored in cells and released in response to reduced pH (the alkaline/acid scale whereby the lower the pH, the more acidic a solution is)
N-hexanoic-tyr-ile-(6) Aminohexanoic Amide 2.3.2 Depositor-Supplied Synonyms 1